Patients with B-cell malignancies experience reduced antibody responses with class switching defect following BNT162b2 SARS-CoV-2 vaccination

Vaccines having aided in escaping the majority of the population from immunological naïvety, our strategies are now shifting towards an increased focus on identifying and protecting the extremely vulnerable. We here describe the results of testing 12 patients, those with lymphoid malignancies having...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagama, Yu, Chi, Sung-Gi, Minami, Yosuke, Watanabe, Reiko, Yamagishi, Michiteru, Atsuko, Uno, Kido, Yasutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509017/
https://www.ncbi.nlm.nih.gov/pubmed/36167304
http://dx.doi.org/10.1016/j.jiac.2022.09.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509017/
https://www.ncbi.nlm.nih.gov/pubmed/36167304
http://dx.doi.org/10.1016/j.jiac.2022.09.018

Ejemplares similares